Osimertinib-induced lymphocytopenia and pneumocystis jirovecii pneumonia
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:28 |
|---|---|
| Enthalten in: |
Pulmonology - 28(2022), 5 vom: 30. Sept., Seite 403-405 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Takechi, H [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
3C06JJ0Z2O |
|---|
| Anmerkungen: |
Date Completed 08.09.2022 Date Revised 09.09.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.pulmoe.2022.04.005 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM342228226 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM342228226 | ||
| 003 | DE-627 | ||
| 005 | 20231226013623.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.pulmoe.2022.04.005 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1140.xml |
| 035 | |a (DE-627)NLM342228226 | ||
| 035 | |a (NLM)35701337 | ||
| 035 | |a (PII)S2531-0437(22)00110-6 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Takechi, H |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Osimertinib-induced lymphocytopenia and pneumocystis jirovecii pneumonia |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 08.09.2022 | ||
| 500 | |a Date Revised 09.09.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Epidermal growth factor receptor (EGFR)-mutation | |
| 650 | 4 | |a Lung adenocarcinoma | |
| 650 | 4 | |a Lymphocytopenia | |
| 650 | 4 | |a Osimertinib | |
| 650 | 4 | |a Pneumocystis jirovecii pneumonia | |
| 650 | 7 | |a Acrylamides |2 NLM | |
| 650 | 7 | |a Aniline Compounds |2 NLM | |
| 650 | 7 | |a Indoles |2 NLM | |
| 650 | 7 | |a Pyrimidines |2 NLM | |
| 650 | 7 | |a osimertinib |2 NLM | |
| 650 | 7 | |a 3C06JJ0Z2O |2 NLM | |
| 700 | 1 | |a Endoh, H |e verfasserin |4 aut | |
| 700 | 1 | |a Hata, Y |e verfasserin |4 aut | |
| 700 | 1 | |a Wasamoto, S |e verfasserin |4 aut | |
| 700 | 1 | |a Yanagisawa, S |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Pulmonology |d 2017 |g 28(2022), 5 vom: 30. Sept., Seite 403-405 |w (DE-627)NLM278404561 |x 2531-0437 |7 nnns |
| 773 | 1 | 8 | |g volume:28 |g year:2022 |g number:5 |g day:30 |g month:09 |g pages:403-405 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.pulmoe.2022.04.005 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 28 |j 2022 |e 5 |b 30 |c 09 |h 403-405 | ||